Cordis appoints Christian Spaulding
pharmafile | March 30, 2010 | Appointment | | Cordis, Johnson & Johnson, appointment, research and development
Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs.
He assumes the role, which will see him lead the company’s global clinical strategy, on 1 June and will be based in Paris.
“I’m excited to join Cordis,” said Spaulding. “As an interventional cardiologist, I’ve enjoyed working with the corporation as an investigator. I valued the company’s high quality standards for devices and ethics in clinical research.
“This is a fantastic opportunity to continue innovating with new devices developed by Cordis and have a positive impact on patient outcomes.”
Dr Spaulding is currently director of the Cardiac Catheterization Laboratory at Cochin Hospital and professor of medicine at René Descartes University, both located in Paris, France.
Related Content

Charity commits £800,000 to AI research into late breast cancer recurrence
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate …

Campaign highlights low expectations among patients with depression
A new global awareness campaign from Johnson & Johnson is aiming to encourage people with …

Johnson & Johnson submits robotic surgical system for De Novo classification
Johnson & Johnson has announced the submission of its Ottava Robotic Surgical System for De …






